Teva, GSK Spar Over Applying Pom Wonderful Ruling to False-Ad Lawsuit

Drug Industry Daily
Teva is pointing to the Supreme Court’s recent ruling in a soft drink labeling case to claim immunity from GlaxoSmithKline’s lawsuit alleging the Israeli firm falsely advertised its generic antidepressant budeprion XL as bioequivalent to GSK’s Wellbutrin XL. 

To View This Article:


Subscribe To Drug Industry Daily